← Product Code [DRF](/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DRF) · K043257 # REAL-TIME POSITION MANAGEMENT (RPM) SYSTEM (K043257) _Ep Technologies, Inc. · DRF · Feb 3, 2005 · Cardiovascular · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DRF/K043257 ## Device Facts - **Applicant:** Ep Technologies, Inc. - **Product Code:** [DRF](/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DRF.md) - **Decision Date:** Feb 3, 2005 - **Decision:** SESE - **Submission Type:** Special - **Regulation:** 21 CFR 870.1220 - **Device Class:** Class 2 - **Review Panel:** Cardiovascular - **Attributes:** Therapeutic ## Indications for Use The Boston Scientific Tracking diagnostic catheters are indicated for cardiac electrophysiological mapping and delivering pacing stimuli. In addition, the Tracking and Reference Catheters are used with the Real-time Position Management (RPMTM) System to provide catheter location information. The Signal Acquisition Module (SAM) is a component of the RPM™ System and supports the above indication. ## Device Story The Signal Acquisition Module (SAM) is an amplifier component of the Real-time Position Management (RPM) System. It collects cardiac signals from up to 48 standard EP catheter electrodes, up to 64 electrodes via expansion pods, 12-lead EKG, two pressure transducers, and two pacing inputs. The SAM applies gain and filter settings programmed via the Mapping System software and transmits data over a fiber optic link to the Arrhythmia Mapping Computer (AMC) for processing and display. Used in clinical settings by physicians for cardiac electrophysiological mapping and pacing. The system provides real-time catheter location and signal visualization, assisting clinicians in diagnosing and treating arrhythmias. ## Clinical Evidence Bench testing only. No clinical data presented. ## Technological Characteristics 128-channel signal processing unit; fiber optic data link; inputs include EP catheters, EKG, pressure transducers, and pacing stimulators. Uses Driven Right Leg Reference. Software-controlled gain and filtering. Class II device. ## Regulatory Identification An electrode recording catheter or an electrode recording probe is a device used to detect an intracardiac electrocardiogram, or to detect cardiac output or left-to-right heart shunts. The device may be unipolar or multipolar for electrocardiogram detection, or may be a platinum-tipped catheter which senses the presence of a special indicator for cardiac output or left-to-right heart shunt determinations. ## Predicate Devices - Arrhythmia Mapping and Tracking System ([K992912](/device/K992912.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ K043257/SI \$ 1 of 3 FEB - 3 2005 ## 1. 510(k) Summary # a. General Information ## Modified Device Information | Category: | Comments: | |--------------------------|---------------------------------------------------------------------------------------------------------------------------------------| | Sponsor: | Boston Scientific Corporation
2710 Orchard Parkway
San Jose, Ca 95134 - | | Correspondent: | Todd G. Brill
Senior Specialist, Regulatory Affairs
Boston Scientific Corporation
2710 Orchard Parkway
San Jose, Ca 95134 | | Contact Information: | E-mail: brillt@bsci.com
Phone: (408) 895-3564
Fax: (408) 895-2202 | | Device Common Name: | Signal Acquisition Module (SAM) | | Device Proprietary Name: | Arrhythmia Mapping System with Real-time
Position Management (RPM™) | | Device Classification: | 21 CFR §870.1220 | # Predicate Device Information | Predicate Device: | Arrhythmia Mapping and Tracking System
(K992912) | |-----------------------------------------|-----------------------------------------------------| | Predicate Device Manufacturer: | Boston Scientific Corporation | | Predicate Device Common Name | Signal Acquisition Module (SAM) | | Predicate Device Classification: | 21 CFR §870.1220 | | Predicate Device Classification Number: | Class II | # b. Date Summary Prepared : January 13, 2005 {1}------------------------------------------------ ## Description of Device C. Signal Acquisition Module (SAM): One of three main components of the RPM™ System that includes the Arrhythmia Mapping Computer (AMC) and the Position Acquisition Module (PAM). The SAM is an amplifier that filters cardiac signal data and transfers it to the AMC for processing and display. The SAM collects the following input signals, applies gain and filter settings as programmed through the Mapping System software and transfers them to the computer over the fiber optic data link for further processing and display. - 1. one or more standard EP catheter electrodes (up to 48 catheter inputs) - 2. two pacing inputs from an external pacing stimulator, which the Mapping System software can route to any catheter bipole or unipole - 3. a synch output channel that can be used with pacing stimulators to synchronize pacing inputs - 4. a 12-lead EKG - 5. two pressure transducer inputs - 6. One 64 electrode Constellation™ Catheter or up to 64 individual catheter inputs through bedside Expansion Pods ## d. Intended Use The Boston Scientific Tracking diagnostic catheters are indicated for cardiac electrophysiological mapping and delivering pacing stimuli. In addition, the Tracking and Reference Catheters are used with the Real-time Position Management (RPMTM) System to provide catheter location information. The Signal Acquisition Module (SAM) is a component of the RPM™ System and supports the above indication. ### Comparison to Predicate Device e. The Modified Signal Acquisition Module (SAM) has the same intended use as the predicate device and was validated to perform as the original device without the {2}------------------------------------------------ options of choosing a system reference for the catheters. The modified device makes sole use of the Driven Right Leg Reference. | Table 1 - Comparison of Device Characteristics to Predicate | | | | |-------------------------------------------------------------|--|--|--| |-------------------------------------------------------------|--|--|--| | Component | Arrhythmia Mapping and Tracking
System | Real-time Position Management
(RPMTM) | |---------------------------------------|-------------------------------------------------------------------------|--------------------------------------------| | | K992912 | K043257 | | | 64 Channel Signal Processing Unit | 128 Channel Signal Processing Unit: | | | > 48 Intra-cardiac | > 112 Intra-cardiac | | | > 12 EKG | > 12 EKG | | | > System Reference - EKG Input - | > System Reference - Driven Right | | | 2 Options | Leg | | | o Catheter Reference | | | Signal
Acquisition
Module (SAM) | o Right Leg Reference | | | | > 2 Pressure | > 2 Pressure | | | > 2 Pacing | > 2 Pacing | | | > Dynamic Diode - Minimize
Pacing Artifacts | > Dynamic Diode - Removed | | | > Post Pace Blanking Interval -
Software to support Dynamic
Diode | > Post Pace Blanking Interval -
Removed | ## Summary of the Non-clinical Data f. Where appropriate, testing conformed to the requirements of 21 CFR Part 58 (Good Laboratory Practices (GLP)). Specifically, non-clinical tests conducted for the Device showed the device met its design-input criteria, and was safe and effective for its intended use. {3}------------------------------------------------ DEPARTMENT OF HEALTH & HUMAN SERVICES Image /page/3/Picture/11 description: The image shows a circular logo for the U.S. Department of Health & Human Services. The logo features the department's name encircling a symbol. The symbol consists of three curved lines that appear to be flowing or waving. The text is arranged around the perimeter of the circle. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 FEB - 3 2005 Boston Scientific Corporation c/o Mr. Todd Brill Senior Specialist, Regulatory Affairs 2710 Orchard Parkway San Jose, CA 95134 Re: K043257 Trade Name: Real-Time Position Management (RPMTM) System Regulation Number: 21 CFR 870.1220 Regulation Name: 21 CFFC 87072220 Regulation Name: Electrode Recording Catheter or Electrode Recording Probe Regulatory Class: II (two) Product Code: DRF Dated: January 12, 2005 Received: January 14, 2005 Dear Mr. Brill: We have reviewed your Section 510(k) premarket notification of intent to market the device we have reviewed your Section 9 ro(x) premained is substantially equivalent (for the indications felerenced above and nave determined we are and and the marketed in interstate for use stated in the encrosule) to regary manological Device Amendments, or to commerce prior to May 28, 1976, the enactment date of the Enderel Food. Drug commerce prof to May 20, 1978, the enaordance with the provisions of the Federal Food. Drug. devices that have been reclassified in accordance with as personal application (PMA). and Cosmetic Act (Act) that do not require approval of a premarket approval application and Cosment Act (Act) that do not require approvinces of the general controls provisions of the Act. The You may, mercefore, market the devices, boys requirements for annual registration, listing of general controls provisions of the Act include requirements for annual registere general controls provisions of the flections and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it If your device is classified (see above) the existing major regulations affecting your device can may be subject to such additional controls. Existing may on and divises EDA may be subject to such additional connoits. Title 21, Parts 800 to 898. In addition, FDA may oc found in the Oous of events concerning your device in the Federal Register. {4}------------------------------------------------ ## Page 2 - Mr. Todd Brill i Please be advised that FDA's issuance of a substantial equivalence determination does not mean Please be advised that 1 Dris issuated on a substition. that FDA has made a determination that your device complies with other requirements of the Act that IDA has made a colorimiation administered by other Federal agencies. You must of ally rederal statutes and regulanents ancluding, but not limited to: registration and listing (21 Comply with an the Act 31equirements, networks, welling practice requirements as set CFK Part 807), labeling (21 CFR Part 807), good ff applicable, the electronic form in the quality systems (Sections 531-542 of the Act); 21 CFR 1000-1050. product radiation control pro neeting your device as described in your Section 510(k) This letter witi anow you to oegin mainer of substantial equivalence of your device to a legally premarket notification. The FDA miding of castion for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please If you desire specific advice ion your are (301) 594-4646. Also, please note the regulation entitled, Contact the Office of Companies and (21CFR Part 807.97) you may obtain. Misorallumg by reference to premarkoonsibilities under the Act may be obtained from the Other general mionmation on your responsional and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html Sincerely yours, _ B/Zimmerman for B. Zimmerman, M.D. Bram B. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {5}------------------------------------------------ # Indications for Use K043257 510(k) Number: Real-time Position Management (RPM™) Device Name: Indications for Use: The Boston Scientific Tracking diagnostic catheters are indicated for cardiac electrophysiological mapping and delivering pacing stimuli. In addition, the Tracking and Reference Catheters are used with the Real-time Positions Management (RPM™) System to provide catheter location information. Prescription Use (Part 21CFR 801 Subpart D) AND/OR Over-the-Counter Use (Part 21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE – CONTINUE ON ANOTHER PAGE IS NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Blumima (Division Sign-Off) Division of Cardiovascular Devices 510(k) Number K0/3257 Page 1 of 1 --- **Source:** [https://fda.innolitics.com/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DRF/K043257](https://fda.innolitics.com/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DRF/K043257) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com